Monitoring of Minimal Residual Disease in <i>NPM1</i> -Mutated Acute Myeloid Leukemia: A Study From the German-Austrian Acute Myeloid Leukemia Study GroupJan Krönke, Konstanze Döhner, Karina Eiwen et al.|Journal of Clinical Oncology|2011Cited by 393
Proteomic profiling reveals CDK6 upregulation as a targetable resistance mechanism for lenalidomide in multiple myelomaYuen Lam Dora Ng, Jan Krönke|Nature Communications|2022Cited by 67
Functional characterization of BRCC3 mutations in acute myeloid leukemia with t(8;21)(q22;q22.1)Tatjana Meyer, Jan Krönke|Leukemia|2019Cited by 28
Teclistamab in relapsed systemic sclerosis after autologous haematopoietic stem cell transplantationElise Siegert, Tobias Alexander, Robert Biesen et al.|Annals of the Rheumatic Diseases|2025Cited by 15